Search
Research
Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetesLess than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID) systems, which are now recommended as gold-standard T1D care. Our Australian AID trial shows a wide spectrum of adults with T1D can achieve recommended targets. Other studies, including lived experience data, are supportive. Insulin pumps are not subsidised for most Australian adults with T1D. We advocate change.
Read about the management staff of the Children's Diabetes Centre, Dr Charles Czank and Nirubasini Paramalingam.
Our Centre is involved with a wide range of research projects, many involving collaborating with partners to run trials of new technologies and treatments.
Our research group is looking for patterns in newly diagnosed diabetic patients in WA to understand the characteristics and risk factors of children with T1D.
Find out how to participate in our research and community group
News & Events
Capacity Building Grants now openThe Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited to offer Type 1 Diabetes (T1D) researchers and Higher Degree by Research (HDR) students affiliated with the Global CoE, the opportunity to apply for sponsorship for training or capacity building related activities.
News & Events
Sports star awardWe are proud to have so many very talented children and youth in our T1D community.
News & Events
School holiday campDuring the recent school holidays, the Diabetes WA and Perth Children’s Hospital again ran a school holiday camp for kids living with type 1 diabetes.
News & Events
Supporting Families Project UpdateIn early 2024, Dr Aveni Haynes and her team were awarded Telethon Trust funding for their project Supporting Families.